Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects using the Lifetech™ Konar-MF Occluder device (MFO)

E Odemis, MH Kizilkaya - Cardiology in the Young, 2023 - cambridge.org
Background: Transcatheter closure of perimembranous ventricular septal defects is
challenging. Double disk-designed devices have high adverse event rates; therefore …
被引用次数：2 相关文章

Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects using the Lifetech™ Konar-MF Occluder device (MFO)

E Odemis, MH Kizilkaya - Cardiology in the young, 2023 - pubmed.ncbi.nlm.nih.gov
Background Transcatheter closure of perimembranous ventricular septal defects is
challenging. Double disk-designed devices have high adverse event rates; therefore …

Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects by using Lifetech™ Konar-MF Occluder device (MFO) …

E Odemis, MH Kizilkaya - scholar.archive.org
Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal
defects by using Lifetech™ K Page 1 Cardiology in the Young cambridge.org/cty …

Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects using the Lifetech™ Konar-MF Occluder device (MFO).

E Odemis, MH Kizilkaya - Cardiology in the Young, 2022 - europepmc.org
Background Transcatheter closure of perimembranous ventricular septal defects is
challenging. Double disk-designed devices have high adverse event rates; therefore …

Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects by using Lifetech™ Konar-MF Occluder device (MFO) …

E Odemis, MH Kizilkaya - Cardiology in the Young, 2023 - cambridge.org
The authors apologise that within the abstract and later in the article the sentence “In the
follow-up, at 6th months, only four patients had hemodynamically significant residual …

[引用][C] Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects by using Lifetech™ Konar-MF Occluder device (MFO) …

E Odemis, MH Kizilkaya - Cardiology in the young, 2023 - pubmed.ncbi.nlm.nih.gov

[引用][C] Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects by using Lifetech™ Konar-MF Occluder device (MFO) …

E Odemis, MH Kizilkaya - Cardiology in the Young, 2022 - europepmc.org
Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal
defects by using Lifetech™ Konar-MF Occluder device (MFO) - CORRIGENDUM. - Abstract …